Premium
P2‐264: THE CNS SPECIFIC PROTEOGLYCAN, BREVICAN, AS A POTENTIAL BLOOD BIOMARKER OF ALZHEIMER'S DISEASE
Author(s) -
Jonesco Ditte S.,
Karsdal Morten,
Henriksen Kim
Publication year - 2019
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2019.06.2671
Subject(s) - western blot , biomarker , microbiology and biotechnology , biology , antibody , monoclonal antibody , epitope , immunology , biochemistry , gene
Karen K. Lazar, Carol A. Van Hulle, Yue Ma, Corinne D. Engelman, Ruocheng Dong, Qiongshi Lu, Carey E. Gleason, Sterling C. Johnson, Barbara B. Bendlin, Kaj Blennow, Henrik Zetterberg, Sanjay Asthana, Cynthia Carlsson, Wisconsin Alzheimer’s Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA; Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA; Department of Biostatistics and Medical Informatics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA; VA Geriatric Research, Education and Clinical Center (GRECC), William S. Middleton Memorial Veterans Hospital, Madison, WI, USA; Wisconsin Alzheimer’s Institute, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA; Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden; Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, M€olndal, Sweden. Contact e-mail: klazar@medicine.wisc.edu